UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000021560
Receipt number R000024772
Scientific Title A study to evaluate the relation between the efficacy and early Immune Related Advers Events of Nivolmab in patients with non-small cell lung cancer
Date of disclosure of the study information 2016/03/24
Last modified on 2023/03/08 19:02:04

No. Disposal Last modified on Item of update
1 Insert 2016/03/22 13:56:10
2 Update 2016/03/25 18:43:38 Recruitment status
3 Update 2016/03/25 18:46:12 UMIN ID1
4 Update 2016/03/25 18:47:38 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
5 Update 2016/04/26 12:07:05 Other related information
Other related information
6 Update 2016/04/26 12:09:21 Other related information
7 Update 2017/04/28 22:00:46 Name of primary person or sponsor
Organization
8 Update 2017/09/23 13:25:10 Last follow-up date
9 Update 2018/04/08 17:46:30 Recruitment status
10 Update 2018/09/23 14:47:18 Publication of results
URL related to results and publications
11 Update 2023/03/08 18:48:54 Recruitment status
Date of IRB
12 Update 2023/03/08 18:51:32 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
13 Update 2023/03/08 19:02:04 URL releasing protocol
Publication of results
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures